vs

Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and Enovis CORP (ENOV). Click either name above to swap in a different company.

Everus Construction Group, Inc. is the larger business by last-quarter revenue ($1.0B vs $548.9M, roughly 1.8× Enovis CORP). Everus Construction Group, Inc. runs the higher net margin — 5.5% vs -104.1%, a 109.5% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs -2.2%). Enovis CORP produced more free cash flow last quarter ($29.1M vs $23.5M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 9.8%).

Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.

ECG vs ENOV — Head-to-Head

Bigger by revenue
ECG
ECG
1.8× larger
ECG
$1.0B
$548.9M
ENOV
Growing faster (revenue YoY)
ECG
ECG
+35.3% gap
ECG
33.2%
-2.2%
ENOV
Higher net margin
ECG
ECG
109.5% more per $
ECG
5.5%
-104.1%
ENOV
More free cash flow
ENOV
ENOV
$5.6M more FCF
ENOV
$29.1M
$23.5M
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
9.8%
ENOV

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ECG
ECG
ENOV
ENOV
Revenue
$1.0B
$548.9M
Net Profit
$55.3M
$-571.1M
Gross Margin
11.6%
59.9%
Operating Margin
6.8%
-101.7%
Net Margin
5.5%
-104.1%
Revenue YoY
33.2%
-2.2%
Net Profit YoY
60.4%
18.8%
EPS (diluted)
$1.09
$-9.99

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECG
ECG
ENOV
ENOV
Q4 25
$1.0B
$548.9M
Q3 25
$986.8M
$564.5M
Q2 25
$921.5M
$558.8M
Q1 25
$826.6M
Q4 24
$759.6M
$561.0M
Q3 24
$761.0M
$505.2M
Q2 24
$703.4M
$525.2M
Q1 24
$625.7M
$516.3M
Net Profit
ECG
ECG
ENOV
ENOV
Q4 25
$55.3M
$-571.1M
Q3 25
$57.0M
$-36.7M
Q2 25
$52.8M
$-56.0M
Q1 25
$36.7M
Q4 24
$34.5M
$-703.2M
Q3 24
$41.8M
$-31.5M
Q2 24
$39.0M
$-18.6M
Q1 24
$28.2M
$-72.0M
Gross Margin
ECG
ECG
ENOV
ENOV
Q4 25
11.6%
59.9%
Q3 25
12.6%
59.3%
Q2 25
13.0%
59.5%
Q1 25
11.2%
Q4 24
11.4%
54.8%
Q3 24
11.8%
56.7%
Q2 24
12.6%
55.0%
Q1 24
11.9%
57.7%
Operating Margin
ECG
ECG
ENOV
ENOV
Q4 25
6.8%
-101.7%
Q3 25
7.3%
-3.0%
Q2 25
7.9%
-8.4%
Q1 25
6.2%
Q4 24
6.1%
-118.5%
Q3 24
7.1%
-6.3%
Q2 24
7.3%
-8.4%
Q1 24
6.2%
-6.8%
Net Margin
ECG
ECG
ENOV
ENOV
Q4 25
5.5%
-104.1%
Q3 25
5.8%
-6.5%
Q2 25
5.7%
-10.0%
Q1 25
4.4%
Q4 24
4.5%
-125.4%
Q3 24
5.5%
-6.2%
Q2 24
5.5%
-3.5%
Q1 24
4.5%
-13.9%
EPS (diluted)
ECG
ECG
ENOV
ENOV
Q4 25
$1.09
$-9.99
Q3 25
$1.11
$-0.64
Q2 25
$1.03
$-0.98
Q1 25
$0.72
Q4 24
$0.68
$-12.69
Q3 24
$0.82
$-0.58
Q2 24
$0.76
$-0.34
Q1 24
$0.55
$-1.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECG
ECG
ENOV
ENOV
Cash + ST InvestmentsLiquidity on hand
$33.6M
Total DebtLower is stronger
$281.5M
$1.4B
Stockholders' EquityBook value
$629.8M
$2.0B
Total Assets
$1.7B
$4.4B
Debt / EquityLower = less leverage
0.45×
0.67×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECG
ECG
ENOV
ENOV
Q4 25
$33.6M
Q3 25
$44.1M
Q2 25
$38.5M
Q1 25
Q4 24
$48.2M
Q3 24
$553.0K
$35.4M
Q2 24
$35.0M
Q1 24
$66.3M
Total Debt
ECG
ECG
ENOV
ENOV
Q4 25
$281.5M
$1.4B
Q3 25
$285.1M
$1.4B
Q2 25
$288.6M
$1.4B
Q1 25
$292.1M
Q4 24
$295.6M
$1.3B
Q3 24
$1.3B
Q2 24
$1.3B
Q1 24
$1.3B
Stockholders' Equity
ECG
ECG
ENOV
ENOV
Q4 25
$629.8M
$2.0B
Q3 25
$573.0M
$2.6B
Q2 25
$514.4M
$2.6B
Q1 25
$460.2M
Q4 24
$422.6M
$2.6B
Q3 24
$453.3M
$3.3B
Q2 24
$490.0M
$3.3B
Q1 24
$464.3M
$3.3B
Total Assets
ECG
ECG
ENOV
ENOV
Q4 25
$1.7B
$4.4B
Q3 25
$1.6B
$5.0B
Q2 25
$1.5B
$4.9B
Q1 25
$1.4B
Q4 24
$1.3B
$4.7B
Q3 24
$1.3B
$5.6B
Q2 24
$5.4B
Q1 24
$5.5B
Debt / Equity
ECG
ECG
ENOV
ENOV
Q4 25
0.45×
0.67×
Q3 25
0.50×
0.54×
Q2 25
0.56×
0.53×
Q1 25
0.63×
Q4 24
0.70×
0.52×
Q3 24
0.40×
Q2 24
0.41×
Q1 24
0.40×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECG
ECG
ENOV
ENOV
Operating Cash FlowLast quarter
$48.2M
$82.6M
Free Cash FlowOCF − Capex
$23.5M
$29.1M
FCF MarginFCF / Revenue
2.3%
5.3%
Capex IntensityCapex / Revenue
2.4%
9.7%
Cash ConversionOCF / Net Profit
0.87×
TTM Free Cash FlowTrailing 4 quarters
$90.0M
$22.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECG
ECG
ENOV
ENOV
Q4 25
$48.2M
$82.6M
Q3 25
$76.2M
$47.8M
Q2 25
$25.3M
$-1.6M
Q1 25
$7.1M
Q4 24
$88.3M
Q3 24
$78.9M
$53.6M
Q2 24
$7.8M
Q1 24
$21.9M
$-36.2M
Free Cash Flow
ECG
ECG
ENOV
ENOV
Q4 25
$23.5M
$29.1M
Q3 25
$65.7M
$3.4M
Q2 25
$12.3M
$-44.9M
Q1 25
$-11.4M
Q4 24
$35.1M
Q3 24
$60.9M
$2.4M
Q2 24
$-31.6M
Q1 24
$12.6M
$-73.1M
FCF Margin
ECG
ECG
ENOV
ENOV
Q4 25
2.3%
5.3%
Q3 25
6.7%
0.6%
Q2 25
1.3%
-8.0%
Q1 25
-1.4%
Q4 24
6.3%
Q3 24
8.0%
0.5%
Q2 24
-6.0%
Q1 24
2.0%
-14.2%
Capex Intensity
ECG
ECG
ENOV
ENOV
Q4 25
2.4%
9.7%
Q3 25
1.1%
7.9%
Q2 25
1.4%
7.7%
Q1 25
2.2%
Q4 24
9.5%
Q3 24
2.4%
10.1%
Q2 24
7.5%
Q1 24
1.5%
7.2%
Cash Conversion
ECG
ECG
ENOV
ENOV
Q4 25
0.87×
Q3 25
1.34×
Q2 25
0.48×
Q1 25
0.19×
Q4 24
Q3 24
1.89×
Q2 24
Q1 24
0.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

ENOV
ENOV

Reconstructive Segment$258.0M47%
Surgical$129.0M23%
Prevention And Recovery$92.6M17%
Other Prevention And Recovery$71.4M13%

Related Comparisons